Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bate

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepinesGema Requena, John Logie, Elisa Martin, et al.
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Pharmaceutics|December 5, 2013
Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan StatisticJeffrey S Brown, Kenneth R Petronis, Andrew Bate, et al.
Drug Safety|August 31, 2014
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculumJürgen Beckmann, Ulrich Hagemann, Priya Bahri, et al.
Drug Safety|June 2, 2026
Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of ExcellenceMohamed A Elhawary, Brian Edwards, Hadir Rostom, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2015
Prevalence of antibiotic use: a comparison across various European health care data sourcesRuth Brauer, Ana Ruigómez, Gerry Downey, et al.
Pharmacoepidemiology and Drug Safety|June 24, 2015
Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU projectGema Requena, Consuelo Huerta, Helga Gardarsdottir, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2015
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU ProjectConsuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Drug Safety|May 7, 2024
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and ElaborationMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepinesGema Requena, John Logie, Elisa Martin, et al.
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Pharmaceutics|December 5, 2013
Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan StatisticJeffrey S Brown, Kenneth R Petronis, Andrew Bate, et al.
Drug Safety|August 31, 2014
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculumJürgen Beckmann, Ulrich Hagemann, Priya Bahri, et al.
Drug Safety|June 2, 2026
Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of ExcellenceMohamed A Elhawary, Brian Edwards, Hadir Rostom, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2015
Prevalence of antibiotic use: a comparison across various European health care data sourcesRuth Brauer, Ana Ruigómez, Gerry Downey, et al.
Pharmacoepidemiology and Drug Safety|June 24, 2015
Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU projectGema Requena, Consuelo Huerta, Helga Gardarsdottir, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2015
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU ProjectConsuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Drug Safety|May 7, 2024
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and ElaborationMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 11